clinical trial · NCT07532226
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Arthritis, Psoriatic
brief summary
This observational study aims to assess the 1-year persistence of guselkumab in adult patients with psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches).
started
Apr 13, 2026
primary completion
Dec 3, 2029
completion
Dec 13, 2029
last updated
Apr 15, 2026
official title
A Real-World, Prospective Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol